Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Evan/ Fa Jones

Director at Veracyte, Inc. (VCYT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M

Reported trades

Filed Stock Type Shares Price Value Since
Nov 26SEC VCYTVeracyte, Inc. Sell Plan 1,10629,362 held (−4%) $50.25 $56K -10.0%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 40873,256 held (−1%) $41.74 $17K +8.4%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 1,12672,130 held (−2%) $43.03 $48K +5.1%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 10,83761,293 held (−15%) $43.80 $475K +3.3%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 5,87255,421 held (−10%) $45.07 $265K +0.4%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 24,29631,125 held (−44%) $45.73 $1.1M -1.1%
Nov 7SEC VCYTVeracyte, Inc. Sell Plan 65730,468 held (−2%) $46.38 $30K -2.5%
  • Sell

    Director Evan/ Fa Jones sold $56K of VCYT at $50.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Evan/ Fa Jones sold $17K of VCYT at $41.74 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Evan/ Fa Jones sold $48K of VCYT at $43.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Evan/ Fa Jones sold $475K of VCYT at $43.80 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Evan/ Fa Jones sold $265K of VCYT at $45.07 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Evan/ Fa Jones sold $1.1M of VCYT at $45.73 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.